BCRX

NASDAQBioCryst Pharmaceuticals Inc
High Tide · 57Squeeze · Watch 32Neutral0 buys · $0Social · No data 0
$8.81
$-0.26 (-2.87%)
15-min delayed · Sep 9, 11:41 PMReal-time →

Score summary

Strong Buy
Analyst Ratings
10Ratings
8 Buy2 Hold0 Sell
Tide Score
57
High Tide · stable · Top 31% of universe (3998)
Outlook66High Tide · stable · Top 18% of universe (3999)
Bootstrap · early days
Squeeze Score
32
Watch ·
  • Days to cover7.97
  • Short interest14.83% of float
  • Borrow rate58.98%
  • Short interest trend+0.05% (30d)
Trend
Neutral
No clear trend (signals split)
Recent Smart Money
0 buys
Quiet · $0 · 14d · 6 super investors

Key statistics

Market Cap
$2.55B
52-week range
$6.24 – $11.11
41% from low
Day range
$9 – $9
Open $9.06
Volume
5.1M
vs 3.1M avg · 165%
P/E (TTM)
7.0
Fwd 10.7
Earnings
Nov 2
53d · est $0.10

Country ranks

US Rank— Country rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 10 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$24
10 Wall St 12-month targets
High
$32
Average
$22
Low
$9
$7$14$20$27$33HIGH$32MEDIAN$23.5LOW$9Mar ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 70/100 Analyst Score (Strong Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.
View full analyst forecast for BCRX

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Nov 2 (post-market, est EPS $0.10) · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Drill deeper
Smart money detail→Fundamentals→Options flow→Analyst breakdown→Short pressure→Technicals→Social pulse→News & PR→

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.